Overview
Wenlan Chen practices in Wuhan, China. Chen is rated as an Advanced expert by MediFind in the treatment of MYH9 Related Thrombocytopenia. Their top areas of expertise are MYH9 Related Thrombocytopenia, Thrombocytopenia, Acute Monoblastic Leukemia (AmoL), and Plasmacytoma.
Their clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of MYH9 Related Thrombocytopenia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- MYH9 Related Thrombocytopenia
- Experienced
- Acute Monoblastic Leukemia (AmoL)
- COVID-19Chen isExperienced. Learn about COVID-19.
- Hearing LossChen isExperienced. Learn about Hearing Loss.
- LeukemiaChen isExperienced. Learn about Leukemia.
- PlasmacytomaChen isExperienced. Learn about Plasmacytoma.
- PneumoniaChen isExperienced. Learn about Pneumonia.